Skip to main content

Table 2 The serum levels of biomarkers

From: Associations of multiple serum biomarkers and the risk of cardiovascular disease in China

biomarkers   n Min 25th 50th 75th Max P
TSH (mIU/L)         0.734
Case 161 0.16 1.36 1.98 2.83 21.99  
Control 160 0.06 1.39 1.95 2.84 12.24  
FT3 (pmol/L)         0.153
Case 161 2.27 4.51 4.99 5.46 7.04  
Control 160 2.03 4.40 4.79 5.38 7.40  
FT4 (pmol/L)         0.032
Case 161 6.30 15.99 17.92 19.43 23.72  
Control 160 10.40 15.01 17.14 19.13 25.02  
T3 (nmol/L)         0.976
Case 161 1.34 1.69 1.98 2.25 3.28  
Control 160 1.28 1.76 1.98 2.20 2.96  
T4 (nmol/L)         0.299
Case 161 49.08 90.66 105.50 118.50 165.30  
Control 160 54.28 86.13 101.45 118.38 168.70  
GLU (mmol/L)         < 0.001
Case 161 1.11 4.95 5.66 6.95 16.46  
Control 160 3.95 4.74 5.10 5.75 14.31  
CREA (μ mol/L)         0.299
Case 161 35.00 51.00 61.00 71.00 160.00  
Control 160 32.00 52.00 60.50 69.00 621.00  
UA (μ mol/L)         0.061
Case 161 45.00 235.50 276.00 328.50 573.00  
Control 160 113.00 217.00 265.00 312.00 638.00  
TC (mmol/L)         0.214
Case 161 2.31 4.27 4.98 5.57 7.67  
Control 160 2.59 4.18 4.72 5.49 8.18  
TG (mmol/L)         < 0.001
Case 161 0.54 1.15 1.61 2.19 9.14  
Control 160 0.34 0.87 1.27 1.72 7.76  
HDL-c (mmol/L)         0.018
Case 161 0.50 0.92 1.06 1.26 2.13  
Control 160 0.50 0.98 1.11 1.32 1.91  
LDL-c (mmol/L)         0.013
Case 161 1.32 2.48 2.89 3.41 6.44  
Control 160 0.97 2.30 2.70 3.15 5.23  
HCY (μ mol/L)         0.693
Case 161 5.50 9.35 11.10 13.50 44.50  
Control 160 4.60 9.60 11.20 13.78 60.70